HIGHLIGHTS
- who: Kun Li and collaborators from the Department of Physiology, College of Basic Medicine, Chongqing Medical University, Chongqing, China have published the paper: EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer, in the Journal: Biomolecules 2022, 12, x FOR PEER REVIEW of 20/Nov/2022
- what: The authors systematically investigated the prognostic value of EIF4G1 in BRCA, determined the association of EIF4G1 with tumor-infiltrating immune cells (TIICs) and immunotherapy response, and screened for potential drugs against BRCA.
- how: The final result was obtained by multiplying the staining intensity and the staining . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.